Considering Stealth Approaches for Allogeneic Therapies to Avoid Immune System Detection
Time: 10:00 am
day: Day One
Details:
• Exploring use of siRNA, shRNA, and microRNA to silence immunogenic signalling in
allogeneic T-cells
• Understanding the benefits awarded to patients by optimising
• Potency vs stealth: evaluating prioritisation of therapy characteristic dependent on
disease type and severity
